The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription

Development

Volumn 132, Issue 12, 2005, Pages 2685-2695

  Tapscott, Stephen J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; HOMEODOMAIN PROTEIN; MYOD PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PAX7;

CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; FIBROBLAST; GENETIC TRANSCRIPTION; MOUSE STRAIN; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMATIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SKELETAL; MYOD PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 21644434750     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01874     Document Type: Review

References (103)

1. Agalioti, T., Lomvardas, S., Parekh, B., Yie, J., Maniatis, T. and Thanos, D. (2000). Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103, 667-678.
2. Ao, W., Gaudet, J., Kent, W. J., Muttumu, S. and Mango, S. E. (2004). Environmentally induced foregut remodeling by PHA-4/FoxA and DAF-12/NHR. Science 305, 1743-1746.
3. Asakura, A., Lyons, G. E. and Tapscott, S. J. (1995). The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev. Biol. 171, 386-398.
4. Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. and Weintraub, H. (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.
5. Bengal, E., Flores, O., Rangarajan, P. N., Chen, A., Weintraub, H. and Verma, I. M. (1994). Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proc. Natl. Acad. Sci. USA 91, 6221-6225.
6. Bergstrom, D. A. and Tapscott, S. J. (2001). Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Mol. Cell. Biol. 21, 2404-2412.
7. Bergstrom, D. A., Penn, B. H., Strand, A., Perry, R. L., Rudnicki, M. A. and Tapscott, S. J. (2002). Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9, 587-600.
8. Berkes, C. A., Bergstrom, D. A., Penn, B. H., Seaver, K. S., Knoepfler, P. S. and Tapscott, S. J. (2004). Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell 14, 465-477.
9. Bertrand, N., Castro, D. S. and Guillemot, F. (2002). Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3, 517-530.
10. Biesiada, E., Hamamori, Y., Kedes, L. and Sartorelli, V. (1999). Myogenic basic helix-loop-helix proteins and Sp1 interact as components of a multiprotein transcriptional complex required for activity of the human cardiac alpha-actin promoter. Mol. Cell. Biol. 19, 2577-2584.
11. Blackwell, T. K. and Weintraub, H. (1990). Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250, 1104-1110.
12. Blais, A., Tsikitis, M., Acosta-Alvear, D., Sharan, R., Kluger, Y. and Dynlacht, B. D. (2005). An initial blueprint for myogenic differentiation. Genes Dev. 19, 553-569.
13. Brennan, T. J., Chakraborty, T. and Olson, E. N. (1991). Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis. Proc. Natl. Acad. Sci. USA 88, 5675-5679.
14. Buchberger, A., Nomokonova, N. and Arnold, H. H. (2003). Myf5 expression in somites and limb buds of mouse embryos is controlled by two distinct distal enhancer activities. Development 130, 3297-3307.
15. Buckingham, M., Bajard, L., Chang, T., Daubas, P., Hadchouel, J., Meilhac, S., Montarras, D., Rocancourt, D. and Relaix, F. (2003) The formation of skeletal muscle: from somite to limb. J. Anat. 202, 59-68.
16. Cheng, T. C., Wallace, M. C., Merlie, J. P. and Olson, E. N. (1993). Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261, 215-218.
17. Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M. and Zaret, K. S. (2002). Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9, 279-289.
18. Cook, D. L., Farley, J. F. and Tapscott, S. J. (2001). A basis for a visual language for describing, archiving and analyzing functional models of complex biological systems. Genome Biol 2, RESEARCH0012.
19. Cossu, G. and Borello, U. (1999). Wnt signaling and the activation of myogenesis in mammals. EMBO J. 18, 6867-6872.
20. Davis, R. J. and Weintraub, H. (1992). Acquisition of myogenic specificity by replacement of three amino acids from MyoD into E12. Science 256, 1027-1030.
21. Davis, R. L., Weintraub, H. and Lassar, A. B. (1987). Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000.
22. Davis, R. L., Cheng, P. F., Lassar, A. B. and Weintraub, H. (1990). The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60, 733-746.
23. De Angelis, L., Borghi, S., Melchionna, R., Berghella, L., Baccarani-Contri, M., Parise, F., Ferrari, S. and Cossu, G. (1998). Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. Proc. Natl. Acad. Sci. USA 95, 12358-12363.
24. de la Serna, I. L., Carlson, K. A. and Imbalzano, A. N. (2001). Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. Nat. Genet. 27, 187-190.
25. de la Serna, I. L., Ohkawa, Y., Berkes, C. A., Bergstrom, D. A., Dacwar, C. S., Tapscott, S. J. and Imbalzano, A. N. (2005). MyoD targets chromatin complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol. Cell. Biol. 25, 3997-4009.
26. Delgado, I., Huang, X., Jones, S., Zhang, L., Hatcher, R., Gao, B. and Zhang, P. (2003). Dynamic gene expression during the onset of myoblast differentiation in vitro. Genomics 82, 109-121.
27. Dilworth, F. J., Seaver, K. S., Fishburn, A., Htet, S. and Tapscott, S. J. (2004). In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation. Proc. Natl. Acad. Sci. USA 101, 11593-11598.
28. Engel, I. and Murre, C. (2001). The function of E- and Id proteins in lymphocyte development. Nat. Rev. Immunol. 1, 193-199.
29. Fulco, M., Schiltz, R. L., Iezzi, S., King, M. T., Zhao, P., Kashiwaya, Y., Hoffman, E., Veech, R. L. and Sartorelli, V. (2003). Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12, 51-62.
30. Gaudet, J. and Mango, S. E. (2002). Regulation of organogenesis by the Caenorhabditis elegans FoxA protein PHA-4. Science 295, 821-825.
31. Gaudet, J., Muttumu, S., Horner, M. and Mango, S. E. (2004). Whole-genome analysis of temporal gene expression during foregut development. PLoS Biol. 2, e352.
32. Gerber, A. N., Klesert, T. R., Bergstrom, D. A. and Tapscott, S. J. (1997). Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11, 436-450.
33. Goldhamer, D. J., Brunk, B. P., Faerman, A., King, A., Shani, M. and Emerson, C. P., Jr (1995). Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 121, 637-649.
34. Greenbaum, S. and Zhuang, Y. (2002). Regulation of early lymphocyte development by E2A family proteins. Semin. Immunol. 14, 405-414.
35. Guarino, M. (1995). Epithehal-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol. Histopathol. 10, 171-184.
36. Gustafsson, M. K., Pan, H., Pinney, D. F., Liu, Y., Lewandowski, A., Epstein, D. J. and Emerson, C. P., Jr (2002). Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification. Genes Dev. 16, 114-126.
37. Hadchouel, J., Carvajal, J. J., Daubas, P., Bajard, L., Chang, T., Rocancourt, D., Cox, D., Summerbell, D., Tajbakhsh, S., Rigby, P. W. et al. (2003). Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus. Development 130, 3126-3415.
38. Hasty, P., Bradley, A., Morris, J. H., Edmondson, D. G., Venuti, J. M., Olson, E. N. and Klein, W. H. (1993). Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364, 501-506.
39. Holtzer, H., Biehl, J., Yeoh, G., Meganathan, R. and Kaji, A. (1975a). Effect of oncogenic virus on muscle differentiation. Proc. Natl. Acad. Sci. USA 72, 4051-4055.
40. Holtzer, H., Rubinstein, N., Fellini, S., Yeoh, G., Chi, J., Birnbaum, J. and Okayama, M. (1975b). Lineages, quantal cell cycles, and the generation of cell diversity. Q. Rev. Biophys. 8, 523-557.
41. Jen, Y., Weintraub, H. and Benezra, R. (1992). Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 6, 1466-1479.
42. Jones, P. A., Wolkowicz, M. J., Rideout, W. M., 3rd, Gonzales, F. A., Marziasz, C. M., Coetzee, G. A. and Tapscott, S. J. (1990). De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. USA 87, 6117-6121.
43. Kablar, B., Asakura, A., Krastel, K., Ying, C., May, L. L., Goldhamer, D. J. and Rudnicki, M. A. (1998). MyoD and Myf5 define the specification of musculature of distinct embryonic origin. Biochem. Cell Biol. 76, 1079-1091.
44. Kadesch, T., Zervos, P. and Ruezinsky, D. (1986). Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. Nucleic Acids Res. 14, 8209-8221.
45. Kassar-Duchossoy, L., Gayraud-Morel, B., Gomes, D., Rocancourt, D., Buckingham, M., Shinin, V. and Tajbakhsh, S. (2004). Mrf4 determines skeletal muscle identitiy in Myf5:MyoD double-mutant mice. Nature 431, 466-471.
46. Khan, J., Bittner, M. L., Saal, L. H., Teichmann, U., Azorsa, D. O., Gooden, G. C., Pavan, W. J., Trent, J. M. and Meltzer, P. S. (1999). cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA 96, 13264-13269.
47. Kitzmann, M. and Fernandez, A. (2001). Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol. Life Sci. 58, 571-579.
48. Knoepfler, P. S., Bergstrom, D. A., Uetsuki, T., Dac-Korytko, I., Sun, Y. H., Wright, W. E., Tapscott, S. J. and Kamps, M. P. (1999). A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res. 27, 3752-3761.
49. Kopan, R., Nye, J. S. and Weintraub, H. (1994). The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 120, 2385-2396.
50. Kraut, N., Snider, L., Chen, C. M., Tapscott, S. J. and Groudine, M. (1998). Requirement of the mouse 1-mfa gene for placental development and skeletal patterning. EMBO J. 17, 6276-6288.
51. Lassar, A. B., Paterson, B. M. and Weintraub, H. (1986). Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47, 649-656.
52. Lassar, A. B., Davis, R. L., Wright, W. E., Kadesch, T., Murre, C., Voronova, A., Baltimore, D. and Weintraub, H. (1991). Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66, 305-315.
53. Ledent, V. and Vervoort, M. (2001). The basic helix-loop-helix protein family: comparative genomics and phylogenetic analysis. Genome Res. 11, 754-770.
54. Ledent, V., Paquet, O. and Vervoort, M. (2002). Phylogenctic analysis of the human basic helix-loop-helix proteins. Genome Biol. 3, RESEARCH0030.
55. Lee, H., Habas, R. and Abate-Shen, C. (2004). MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis. Science 304, 1675-1678.
56. Leung, T. H., Hoffmann, A. and Baltimore, D. (2004). One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 118, 453-464.
57. Li, L., Zhou, J., James, G., Heller-Harrison, R., Czech, M. P. and Olson, E. N. (1992). FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71, 1181-1194.
58. Litt, M. D., Simpson, M., Gaszner, M., Allis, C. D. and Felsenfeld, G. (2001). Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus. Science 293, 2453-2455.
59. Liu, S., Spinner, D. S., Schmidt, M. M., Danielsson, J. A., Wang, S. and Schmidt, J. (2000). Interaction of MyoD family proteins with enhancers of acetylcholine receptor subunit genes in vivo. J. Biol. Chem. 275, 41364-41368.
60. Ma, P. C., Rould, M. A., Weintraub, H. and Pabo, C. O. (1994). Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation. Cell 77, 451-459.
61. Mal, A. and Harter, M. L. (2003). MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc. Natl. Acad Sci. USA 100, 1735-1739.
62. Mal, A., Sturniolo, M., Schiltz, R. L., Ghosh, M. and Harter, M. L. (2001). A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 20, 1739-1753.
63. Markus, M., Du, Z. and Benezra, R. (2002). Enhancer-specific modulation of E protein activity. J. Biol. Chem. 277, 6469-6477.
64. Massari, M. E. and Murre, C. (2000). Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20, 429-440.
65. McKinsey, T. A., Zhang, C. L. and Olson, E. N. (2001). Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11, 497-504.
66. Molkentin, J. D. and Olson, E. N. (1996). Defining the regulatory networks for muscle development. Curr. Opin. Genet. Dev. 6, 445-453.
67. Molkentin, J. D., Black, B. L., Martin, J. F. and Olson, E. N. (1995). Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83, 1125-1136.
68. Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C. V., Buskin, J. N., Hauschka, S. D., Lassar, A. B. et al. (1989). Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537-544.
69. Nabeshima, Y., Hanaoka, K., Hayasaka, M., Esumi, E., Li, S. and Nonaka, I. (1993). Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535.
70. Nofziger, D., Miyamoto, A., Lyons, K. M. and Weinmaster, G. (1999). Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126, 1689-1702.
71. Penn, B. H., Bergstrom, D. A., Dilworth, F. J., Bengal, E. and Tapscott, S. J. (2004). A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes Dev. 18, 2348-2353.
72. Perry, R. L., Parker, M. H. and Rudnicki, M. A. (2001). Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8, 291-301.
73. Pichaud, F. and Desplan, C. (2002). Pax genes and eye organogenesis. Curr. Opin. Genet. Dev. 12, 430-434.
74. Pownall, M. E., Gustafsson, M. K. and Emerson, C. P., Jr (2002). Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu. Rev. Cell Dev. Biol. 18, 747-783.
75. Puri, P. L. and Sartorelli, V. (2000). Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J. Cell Physiol. 185, 155-173.
76. Puri, P. L., Avantaggiati, M. L., Balsano, C., Sang, N., Graessmann, A., Giordano, A. and Levrero, M. (1997a). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16, 369-383.
77. Puri, P. L., Sartorelli, V., Yang, X. J., Hamamori, Y., Ogryzko, V. V., Howard, B. H., Kedes, L., Wang, J. Y., Graessmann, A., Nakatani, Y. et al. (1997b). Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1, 35-45.
78. Rudnicki, M. A., Schnegelsberg, P. N., Stead, R. H., Braun, T., Arnold, H. H. and Jaenisch, R. (1993). MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359.
79. Sartorelli, V., Webster, K. A. and Kedes, L. (1990). Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1. Genes Dev. 4, 1811-1822.
80. Sartorelli, V., Huang, J., Hamamori, Y. and Kedes, L. (1997). Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell Biol. 17, 1010-1026.
81. Sartorelli, V., Puri, P. L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J. Y. and Kedes, L. (1999). Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4, 725-734.
82. Silberstein, L., Webster, S. G., Travis, M. and Blau, H. M. (1986). Developmental progression of myosin gene expression in cultured muscle cells. Cell 46, 1075-1081.
83. Silver, S. J. and Rebay, I. (2005). Signaling circuitries in development: insights from the retinal determination gene network. Development 132, 3-13.
84. Simone, C., Forcales, S. V., Hill, D. A., Imbalzano, A. N., Latella, L. and Puri, P. L. (2004). p38 pathway targets SWI-SNF chromatin remodeling complex to muscle-specific loci. Nat. Genet. 36, 738-743.
85. Tajbakhsh, S., Vivarelli, E., Cusella-De, Angelis, G., Rocancourt, D., Buckingham, M. and Cossu, G. (1994). A population of myogenic cells derived from the mouse neural tube. Neuron 13, 813-821.
86. Tajbakhsh, S., Rocancourt, D., Cossu, G. and Buckingham, M. (1997). Redefining the generic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127-138.
87. Taylor, S. M. and Jones, P. A. (1979). Multiple new phenotypes induced in 10T1/2 cells treated with 5-azacytidine. Cell 17, 771-779.
88. Teboul, L., Summerbell, D. and Rigby, P. W. (2003). The initial somitic phase of Myf5 expression requires neither Shh signaling nor Gli regulation. Genes Dev. 17, 2870-2874.
89. Thayer, M. J. and Weintraub, H. (1990). Activation and repression of myogenesis in somatic cell hybrids: evidence for trans-negative regulation of MyoD in primary fibroblasts. Cell 63, 23-32.
90. Thayer, M. J., Tapscott, S. J., Davis, R. L., Wright, W. E., Lassar, A. B. and Weintraub, H. (1989). Positive autoregulation of the myogenic determination gene MyoD1. Cell 58, 241-248.
91. Tomczak, K. K., Marinescu, V. D., Ramoni, M. F., Sanoudou, D., Montanaro, F., Han, M., Kunkel, L. M., Kohane, I. S. and Beggs, A. H. (2004). Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J. 18, 403-405.
92. Wang, Y. and Jaenisch, R. (1997). Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. Development 124, 2507-2513.
93. Weintraub, H. (1972). A possible role for histone in the synthesis of DNA. Nature 240, 449-453.
94. Weintraub, H. and Groudine, M. (1976). Chromosomal subunits in active genes have an altered conformation. Science 193, 848-856.
95. Weintraub, H., Campbell, G. L. and Holtzer, H. (1973). Differentiation in the presence of bromodeoxyuridine is "all-or-none". Nat. New Biol. 244, 140-142.
96. Weintraub, H., Tapscott, S. J., Davis, R. L., Thayer, M. J., Adam, M. A., Lassar, A. B. and Miller, A. D. (1989). Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA 86, 5434-5438.
97. Weintraub, H., Davis, R., Lockshon, D. and Lassar, A. (1990). MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87, 5623-5627.
98. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., Hollenberg, S. et al. (1991a). The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251, 761-766.
99. Weintraub, H., Dwarki, V. J., Verma, I., Davis, R. L., Hollenberg, S., Snider, L., Lassar, A. B. and Tapscott, S. J. (1991b). Muscle-specific transcriptional activation by MyoD. Genes Dev. 5, 1377-1386.
100. Westerman, B. A., Murre, C. and Oudejans, C. B. (2003). The cellular Pax-Hox-helix connection. Biochim. Biophys. Acta. 1629, 1-7.
101. Wold, B., Wigler, M., Lacy, E., Maniatis, T., Silverstein, S. and Axel, R. (1979). Introduction and expression of a rabbit beta-globin gene in mouse fibroblasts. Proc. Natl. Acad. Sci. USA 76, 5684-5688.
102. Woloshin, P., Song, K., Degnin, C., Killary, A. M., Goldhamer, D. J., Sassoon, D. and Thayer, M. J. (1995). MSX1 inhibits myoD expression in fibroblast × 10T1/2 cell hybrids. Cell 82, 611-620.
103. Zhu, Z. and Miller, J. B. (1997). MRF4 can substitute for myogenin during early stages of myogenesis. Dev. Dyn. 209, 233-241.